H7HLAII DNA Influenza Vaccine Phase I Trial
Conditions: Influenza A; Pandemic Influenza Intervention: Biological: H7HLAII Sponsor: Oslo University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Flu Pandemic | Hospitals | Influenza | Influenza Vaccine | Pandemics | Research | Vaccines